Novacyt Stock price

Equities

ALNOV

FR0010397232

Biotechnology & Medical Research

Market Closed - Euronext Paris 12:27:16 2024-03-18 pm EDT 5-day change 1st Jan Change
0.54 EUR -0.92% Intraday chart for Novacyt +6.82% -24.26%
Sales 2021 95.78M 104M Sales 2022 21.04M 22.87M Capitalization 76.79M 83.48M
Net income 2021 -9M -9.78M Net income 2022 -25M -27.18M EV / Sales 2021 1.67 x
Net cash position 2021 99.9M 109M Net cash position 2022 86.29M 93.82M EV / Sales 2022 -0.45 x
P/E ratio 2021
-26.3 x
P/E ratio 2022
-2.99 x
Employees 120
Yield 2021 *
-
Yield 2022
-
Free-Float 96.6%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.92%
1 week+6.72%
Current month+4.85%
1 month-3.83%
3 months-27.32%
6 months-35.14%
Current year-24.26%
More quotes
1 week
0.51
Extreme 0.505
0.55
1 month
0.49
Extreme 0.4932
0.57
Current year
0.49
Extreme 0.4932
0.72
1 year
0.42
Extreme 0.42
1.00
3 years
0.42
Extreme 0.42
9.22
5 years
0.06
Extreme 0.0612
13.96
10 years
0.06
Extreme 0.0612
13.96
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 21-01-04
Director of Finance/CFO 41 17-03-31
Chief Tech/Sci/R&D Officer - 16-04-30
Members of the board TitleAgeSince
Director/Board Member 76 15-06-28
Director/Board Member 69 23-09-07
Director/Board Member 51 23-09-07
More insiders
Date Price Change Volume
24-03-18 0.54 -0.92% 41,860
24-03-15 0.545 +2.83% 104,881
24-03-14 0.53 0.00% 32,160
24-03-13 0.53 +2.32% 65,143
24-03-12 0.518 +2.47% 53,942

Real-time Euronext Paris, March 18, 2024 at 12:27 pm EDT

More quotes
Novacyt develops, produces, and sells in vitro and molecular diagnostic products for the microbiology, haematology and serology markets. The activity is organized around two sectors: - development of solutions and diagnostic services. The group is also developing a manufacturing activity for reagents and kits for bacterial and blood tests; - manufacture and sale of molecular screening kits (Primerdesign): for laboratories.
More about the company

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Novacyt - Euronext Paris